Total raised
$900K
Last: Seed 2020-03
Stage
Seed
Founded
2019
Headcount
3
HQ
Nazareth
Sector
Health Tech & Life Sciences
About
Cuspa is developing an artificial cusp for use in treating aortic valve insufficiency (AI), a heart disorder in which the valve does not close properly and allows blood to flow backward into the heart. The companys CUSPER is an artificial cusp, connected to a grasper, that is attached to the native valve cusp/leaflet for the treatment of AI.
Cusper is attached to the native aortic valve cusp using a nitinol grasper, it preserves the functionality of an healthy aortic and prevents valve insuffiency. After demonstrating proof of concept, Cuspa Medical is carrying out pre-clinical studies on pigs, with the objective to optimize Cusper‘s performance.
Funding history · 1 round · $900K total
2020-03
Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Cuspa's primary focus in medical device development?
- Cuspa is developing an artificial cusp, named CUSPER, for the transcatheter treatment of aortic valve insufficiency (AI), a heart disorder where the valve does not close properly.
- When was Cuspa founded?
- Cuspa was founded in August 2019.
- Where is Cuspa's headquarters located?
- Cuspa's headquarters is in Nazareth, North District, Israel.
- What is the current stage of Cuspa's product development?
- Cuspa's product, CUSPER, is currently in the clinical trial stage, specifically undergoing pre-clinical studies on pigs to optimize its performance after demonstrating proof of concept.
- Which investor participated in Cuspa's Seed funding round?
- NGT3 was an investor in Cuspa's Seed funding round in March 2020.
- How much grant funding did Cuspa receive in July 2024?
- In July 2024, Cuspa received a grant of $900,000 from the IIA (Israel Innovation Authority).
- What is the estimated employee count for Cuspa?
- Cuspa has 3 employees, falling within the 1-10 employee bucket.
- Who is a co-founder of Cuspa?
- Yair Feld is a co-founder of Cuspa.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
heart-diseasesminimally-invasivecardiologycardiovascularvalvesmedical-devicescatheters